↓ Skip to main content

Cochrane Database of Systematic Reviews

Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease

Overview of attention for article published in this source, December 2011
Altmetric Badge

Mentioned by

10 tweeters
1 Facebook page
14 Wikipedia pages


39 Dimensions

Readers on

109 Mendeley
1 CiteULike
Inhaled corticosteroids versus long-acting beta<sub>2</sub>-agonists for chronic obstructive pulmonary disease
Published by
John Wiley & Sons, Ltd, December 2011
DOI 10.1002/14651858.cd007033.pub3
Pubmed ID

Spencer, Sally, Karner, Charlotta, Cates, Christopher J, Evans, David J


Long-acting beta(2)-agonists and inhaled corticosteroids can be used as maintenance therapy by patients with moderate to severe chronic obstructive pulmonary disease. These interventions are often taken together in a combination inhaler. However, the relative added value of the two individual components is unclear.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Colombia 1 <1%
Unknown 107 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 18 17%
Researcher 12 11%
Student > Bachelor 11 10%
Other 11 10%
Student > Doctoral Student 9 8%
Other 20 18%
Unknown 28 26%
Readers by discipline Count As %
Medicine and Dentistry 54 50%
Nursing and Health Professions 6 6%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Agricultural and Biological Sciences 3 3%
Psychology 3 3%
Other 5 5%
Unknown 33 30%